What is Covishield

On January 30, 2020, the World Health Organization declared the unexpected coronavirus pneumonia pandemic a public health crisis of global significance. COVID-19 in its most severe form can cause coagulation issues and acute respiratory distress syndrome. Due to viral modifications and the advent of new viral strains, the efficiency of traditional treatments for viral infections is rapidly fading. To overcome the limitations and to improve anti-viral treatments, integrated scientific research toward nanotechnology treatment investigations are anticipated for probable use in the prevention and/or treatment of viral infections. This chapter focuses on nano-based diagnostics, accompanied by a study of nano-based therapeutics and treatments that have been shown to be effective against viruses that are closely related to SARS-CoV-2. Furthermore, the authors anticipate that nanotechnology-based approaches mentioned throughout this chapter will aid researchers in developing new COVID-19 prevention, diagnosis, and treatment methods.